C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2002
12/19/2002	US20020193367 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1266897A2 Hypoglycemic imidazoline compounds
12/18/2002	EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
12/18/2002	EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265601A2 Method for treating ocular pain
12/18/2002	EP1119564B1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/17/2002	US6495686 Therapy for psychological disorders
12/17/2002	US6495583 Benzimidazole derivatives
12/17/2002	US6495561 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/12/2002	WO2002099388A2 Benzodiazepine bradykinin antagonists
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098872A1 Isoindolines and process for preparation thereof
12/12/2002	WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002004424A9 Pyrazole derivatives
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	US20020188138 Acylation process
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002	EP1264836A1 Processes for the preparation of indolopyrrolocarbazole derivatives
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264826A1 Novel imidazoline compounds
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/11/2002	EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments
12/11/2002	EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	EP0722446B1 Distamycin a analogues as antitumour or antiviral agents
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	USRE37936 Pesticidal 1-polyarylpyrazoles
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492530 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492387 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
12/10/2002	US6492381 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002	CA2116773C Triazolylated tertiary amine compound or salt thereof
12/10/2002	CA2109934C Substituted indoles as anti-aids pharmaceuticals
12/05/2002	WO2002096902A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096873A1 Isoindole and isoquinoline derivatives as inhibitors of factor xa
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096361A2 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2002056681A3 Novel intermediates and process to pyrimidinedione herbicides
12/05/2002	WO2002036073A3 Receptor antagonist-lipid conjugates and delivery vehicles containing same
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002	US20020183364 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
12/05/2002	US20020183328 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
12/05/2002	US20020183325 Phthalazinone derivatives

1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 626